New bacteria infects cancer patients in Arkansas

Patients who had ports accessed at ACI between March 22 and September 11 of this year are considered at risk


A newly discovered bacteria has infected dozens of cancer patients who received treatments at the Arkansas Cancer Institute (ACI), according to an article on the KARK website.

The epidemiologist at the State Health Department (ADH) said that the bacteria is so new that doctors don't know exactly what it does.

Patients who had ports accessed at ACI between March 22 and September 11 of this year are considered at risk.

"We know that things have gone wrong in the development of their flushes. They have created their own flushes which were supposed to be sterile and they were not sterile," according to an ADH official.   

Read the article.

 

 



November 12, 2018


Topic Area: Infection Control


Recent Posts

Disinfectant Dispensers in Healthcare Facilities Often Fail to Deliver Safe Concentrations: Study

Study of 10 hospitals finds 90 percent have at least one dispenser delivering disinfectants at incorrect concentrations.


Duke University Health System Receives $50 Million for Proton Beam Therapy Center

The donation is the largest philanthropic gift received by Duke University Health System.


UT Southwestern Experiences Data Breach Through Calendar Tool

The incident occurred in October.


Protecting Patient Data: Strategies and Tactics

As cyber threats and breaches grow, healthcare organizations and facilities need a better approach to cybersecurity.


Duke Health to Acquire Lake Norman Regional Medical Center

The closing is projected for the first quarter of 2025.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.